Carlson Capital’s ChemoCentryx, Inc. CCXI Stock Holding History

Carlson Capital’s Portfolio CCXI Stock Details CCXI Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q4	–	Sell	-750,000	Closed	-$38.7M	–	159
2022 Q3	$38.7M	Buy	+750,000	New	+$31M	2.92%	6

Other funds holding CCXI

HNB

Huntington National Bank Columbus, Ohio $18.1B AUM 24.69% 1-Year Est. Return

Carlson Capital's CCXI Position: Q4 2022 in Review

Carlson Capital sold out of ChemoCentryx, Inc. (CCXI) in Q4 2022, closing a stake of 750,000 shares — an estimated $38.7M sold.

Carlson Capital first reported a position in CCXI in Q3 2022 and held it in 1 quarter. The position peaked at $38.7M in Q3 2022. 1 fund tracked by Wall St. Rank holds CCXI as of Q4 2022.

Carlson Capital reported no remaining ChemoCentryx, Inc. position as of Q4 2022 after selling out during the quarter.
Carlson Capital sold 750,000 ChemoCentryx, Inc. shares in Q4 2022, an estimated $38.7M.
Carlson Capital first reported a position in ChemoCentryx, Inc. in Q3 2022 and held it in 1 quarter.
Carlson Capital's ChemoCentryx, Inc. position peaked at $38.7M in Q3 2022.
1 fund tracked by Wall St. Rank held ChemoCentryx, Inc. as of Q4 2022.

Based on Carlson Capital's 13F filing for Q4 2022, filed 14 Feb 2023.